Literature DB >> 6999625

Emission tomography of the heart.

H R Schelbert, E Henze, M E Phelps.   

Abstract

The utility and ultimate role of positron emission computed tomography in health care delivery is difficult to assess at present and needs to be defined in the future. It would seem that with improvements in instrumentation and physiologic indicators, and with the development of compact, reliable, and generator-like cyclotrons, "physiologic tomography" will become more widely applicable. Physiologic tomography of the heart undoubtedly represents an important new tool for investigative studies that will improve our understanding of cardiac physiology in health and disease. The quantiative aspects as well as simultaneous evaluation of more than one segment of myocardial performance, e.g., simultaneous study of mechanical function, blood flow, and metabolism and their interdependency, will provide new insights into myocardial physiology. Because many of the cardiovascular disorders may originate at the cellular or metabolic level, it is hoped that this technique will serve as a means for the early detection of cardiac disease, perhaps at a stage when it is still amenable to therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999625     DOI: 10.1016/s0001-2998(80)80038-9

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  8 in total

1.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; S Nishizawa; N Sadato; E Tadamura; S Ono
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

2.  A convenient route to [68Ga]Ga-MAA for use as a particulate PET perfusion tracer.

Authors:  Carla J Mathias; Mark A Green
Journal:  Appl Radiat Isot       Date:  2008-06-11       Impact factor: 1.513

3.  Experimental studies on myocardial glucose metabolism of rats with 18F-2-fluoro-2-deoxy-D-glucose.

Authors:  K Yamada; S Endo; H Fukuda; Y Abe; S Yoshioka; M Itoh; K Kubota; J Hatazawa; T Satoh; T Matsuzawa
Journal:  Eur J Nucl Med       Date:  1985

4.  PET tomographic imaging of the human heart, pancreas, and liver with nitrogen-13 derived from [13N]-L-glutamate.

Authors:  W G Myers; R E Bigler; R S Benua; M C Graham; J S Laughlin
Journal:  Eur J Nucl Med       Date:  1983

5.  Metabolism of 15 (p 123I iodophenyl-)pentadecanoic acid in heart muscle and noncardiac tissues.

Authors:  S N Reske; W Sauer; H J Machulla; J Knust; C Winkler
Journal:  Eur J Nucl Med       Date:  1985

6.  Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction.

Authors:  N Tamaki; E Tadamura; T Kudoh; N Hattori; Y Yonekura; R Nohara; S Sasayama; K Ikekubo; H Kato; J Konishi
Journal:  Eur J Nucl Med       Date:  1996-03

7.  Effect of myocardial perfusion and metabolic interventions on cardiac kinetics of phenylpentadecanoic acid (IPPA) I 123.

Authors:  S N Reske; S Schön; W Schmitt; H J Machulla; R Knopp; C Winkler
Journal:  Eur J Nucl Med       Date:  1986

8.  Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy.

Authors:  H Sochor; H R Schelbert; M Schwaiger; E Henze; M E Phelps
Journal:  Eur J Nucl Med       Date:  1986
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.